Global Esoteric Testing Market – Global Industry Analysis and Forecast (2017-2026) _ by Type (Infectious Disease, Endocrinology, Oncology, Immunology and Others), by Technology (Mass Spectrometry, CLIA, ELISA, PCR and Others), by Lab Type (Independent & Reference Labs and Hospital Laboratories) and by Geography

Market Scenario

Esoteric Testing Market is expected to reach USD 57.3 Billion by 2026 from USD 18.7 Billion in 2016 at a CAGR of 11.85% (Detailed analysis of the market CAGR is provided in the report). Esoteric testing permits the analysis of rare substances or molecules that cannot perform in a routine clinical laboratory. Esoteric Testing Market The esoteric testing market based on type has been segmented into infectious diseases, immunology, endocrinology, oncology, genetics, toxicology, neurology, and others. The infectious diseases testing type is expected to hold one of the largest market shares for the market. The growth is attributed to a large number of infectious disease tests that are performed in clinical laboratories, technological innovations in molecular diagnostics and increasing healthcare infrastructure in developing nations. Based on laboratory type, the market has been divided into independent & reference laboratories and hospital laboratories. The independent & reference laboratories formed one of the major contributors for the market. The growth is attributed to the continuous automation and digitalization of diagnostic laboratories across the major economies. Geographically, North America is expected to be one of the largest markets and hold one of the largest market shares for esoteric testing. The growing incidence of chronic diseases, increasing awareness of personalized medicine, increasing public and private funding for research on the development of clinical laboratory tests are some of the factors driving the market growth. Key Highlights: • Esoteric testing market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the esoteric testing market. • Esoteric testing market segmentation on the basis type, technology, laboratory type and geography (country-wise) has been provided. • Esoteric testing market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Esoteric testing market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the esoteric testing market are also profiled. Research Methodology: The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the global market value for Esoteric Testing Market.  

Some of the prominent key players operating in the market include

• LabCorp (US) • Quest Diagnostics (US) • OPKO Health (US) • Myriad Genetics (US) • Genomic Health (US) • American Medical Laboratories (US) • Foundation Medicine (US) • Mayo Medical Laboratories (US) • Primary Healthcare (Australia) • Healthscope (Australia) • Sonic Healthcare (Australia) • Fulgent Genetics (US) Key Target Audience: • Independent/reference laboratories • Pharmaceutical, biopharmaceutical, biotechnology companies and Diagnostic companies • Clinical laboratory testing service providers • Suppliers and distributors of diagnostic test kits • Healthcare service providers • OEM manufacturers • Medical institutes • Health insurance players

Scope of the Report

The Research report segments the esoteric testing market based on type, technology, laboratory type and geography Esoteric Testing Market, by Type:

• Infectious Diseases Testing • Endocrinology Testing • Oncology testing • Immunology Testing • Genetic Testing • Toxicology Testing • Neurology Testing • Others

Esoteric Testing Market, by Technology:

• Chemiluminescence Immunoassay (CLIA) • Enzyme-linked Immunosorbent Assay (ELISA) • Mass Spectrometry • Real Time - PCR • Flow Cytometry • Radioimmunoassay • Others

Esoteric Testing Market, by Laboratory Type:

• Independent & Reference Laboratories • Hospital Laboratories

Esoteric Testing Market, by Geography:

• North America • Europe • Asia Pacific • Middle East & Africa • Latin America Geographic Analysis: • Breakdown of North America Esoteric Testing Market • Breakdown of Europe Esoteric Testing Market • Breakdown of Asia Pacific Esoteric Testing Market • Breakdown of Middle East & Africa Esoteric Testing Market • Breakdown of Latin America Esoteric Testing Market Available Customization: Maximize Market Research offers customization of reports according to the specific requirement of our clients. Diabetes management market

Table of Contents

Esoteric Testing Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Esoteric Testing Market Size, by Market Value (US$ Bn ) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Esoteric Testing Market Analysis and Forecast 6.1. Global Esoteric Testing Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Esoteric Testing Market Analysis and Forecast, by Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Esoteric Testing Market Value Share Analysis, by Type 7.4. Global Esoteric Testing Market Size (US$ Bn ) Forecast, by Type 7.5. Global Esoteric Testing Market Analysis, by Type 7.6. Global Esoteric Testing Market Attractiveness Analysis, by Type 8. Global Esoteric Testing Market Analysis and Forecast, by Technology 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Esoteric Testing Market Value Share Analysis, by Technology 8.4. Global Esoteric Testing Market Size (US$ Bn ) Forecast, by Technology 8.5. Global Esoteric Testing Market Analysis, by Technology 8.6. Global Esoteric Testing Market Attractiveness Analysis, by Technology 9. Global Esoteric Testing Market Analysis and Forecast, by Laboratory Type 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Esoteric Testing Market Value Share Analysis, by Laboratory Type 9.4. Global Esoteric Testing Market Size (US$ Bn ) Forecast, by Laboratory Type 9.5. Global Esoteric Testing Market Analysis, by Laboratory Type 9.6. Global Esoteric Testing Market Attractiveness Analysis, by Laboratory Type 10. Global Esoteric Testing Market Analysis, by Region 10.1. Global Esoteric Testing Market Value Share Analysis, by Region 10.2. Global Esoteric Testing Market Size (US$ Bn ) Forecast, by Region 10.3. Global Esoteric Testing Market Attractiveness Analysis, by Region 11. North America Esoteric Testing Market Analysis 11.1. Key Findings 11.2. North America Esoteric Testing Market Overview 11.3. North America Esoteric Testing Market Value Share Analysis, by Type 11.4. North America Esoteric Testing Market Forecast, by Type 11.4.1. Infectious Diseases Testing 11.4.2. Endocrinology Testing 11.4.3. Oncology testing 11.4.4. Immunology Testing 11.4.5. Genetic Testing 11.4.6. Toxicology Testing 11.4.7. Neurology Testing 11.4.8. Others 11.5. North America Esoteric Testing Market Value Share Analysis, by Technology 11.6. North America Esoteric Testing Market Forecast, by Technology 11.6.1. Chemiluminescence Immunoassay (CLIA) 11.6.2. Enzyme-linked Immunosorbent Assay (ELISA) 11.6.3. Mass Spectrometry 11.6.4. Real Time – PCR 11.6.5. Flow Cytometry 11.6.6. Radioimmunoassay 11.6.7. Others 11.7. North America Esoteric Testing Market Value Share Analysis, by Laboratory Type 11.8. North America Esoteric Testing Market Forecast, by Laboratory Type 11.8.1. Independent & Reference Laboratories 11.8.2. Hospital Laboratories 11.9. North America Esoteric Testing Market Value Share Analysis, by Country 11.10. North America Esoteric Testing Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Esoteric Testing Market Analysis, by Country 11.12. U.S. Esoteric Testing Market Forecast, by Type 11.12.1. Infectious Diseases Testing 11.12.2. Endocrinology Testing 11.12.3. Oncology testing 11.12.4. Immunology Testing 11.12.5. Genetic Testing 11.12.6. Toxicology Testing 11.12.7. Neurology Testing 11.12.8. Others 11.13. U.S. Esoteric Testing Market Forecast, by Technology 11.13.1. Chemiluminescence Immunoassay (CLIA) 11.13.2. Enzyme-linked Immunosorbent Assay (ELISA) 11.13.3. Mass Spectrometry 11.13.4. Real Time – PCR 11.13.5. Flow Cytometry 11.13.6. Radioimmunoassay 11.13.7. Others 11.14. U.S. Esoteric Testing Market Forecast, by Laboratory Type 11.14.1. Independent & Reference Laboratories 11.14.2. Hospital Laboratories 11.15. Canada Esoteric Testing Market Forecast, by Type 11.15.1. Infectious Diseases Testing 11.15.2. Endocrinology Testing 11.15.3. Oncology testing 11.15.4. Immunology Testing 11.15.5. Genetic Testing 11.15.6. Toxicology Testing 11.15.7. Neurology Testing 11.15.8. Others l 11.16. Steel Canada Esoteric Testing Market Forecast, by Technology 11.16.1. Chemiluminescence Immunoassay (CLIA) 11.16.2. Enzyme-linked Immunosorbent Assay (ELISA) 11.16.3. Mass Spectrometry 11.16.4. Real Time – PCR 11.16.5. Flow Cytometry 11.16.6. Radioimmunoassay 11.16.7. Others 11.17. Canada Esoteric Testing Market Forecast, by Laboratory Type 11.17.1. Independent & Reference Laboratories 11.17.2. Hospital Laboratories 11.18. North America Esoteric Testing Market Attractiveness Analysis 11.18.1. By Type 11.18.2. By Technology 11.18.3. By Laboratory Type 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Esoteric Testing Market Analysis 12.1. Key Findings 12.2. Europe Esoteric Testing Market Overview 12.3. Europe Esoteric Testing Market Value Share Analysis, by Type 12.4. Europe Esoteric Testing Market Forecast, by Type 12.4.1. Infectious Diseases Testing 12.4.2. Endocrinology Testing 12.4.3. Oncology testing 12.4.4. Immunology Testing 12.4.5. Genetic Testing 12.4.6. Toxicology Testing 12.4.7. Neurology Testing 12.4.8. Others 12.5. Europe Esoteric Testing Market Value Share Analysis, by Technology 12.6. Europe Esoteric Testing Market Forecast, by Technology 12.6.1. Chemiluminescence Immunoassay (CLIA) 12.6.2. Enzyme-linked Immunosorbent Assay (ELISA) 12.6.3. Mass Spectrometry 12.6.4. Real Time – PCR 12.6.5. Flow Cytometry 12.6.6. Radioimmunoassay 12.6.7. Others 12.7. Europe Esoteric Testing Market Value Share Analysis, by Laboratory Type 12.8. Europe Esoteric Testing Market Forecast, by Laboratory Type 12.8.1. Independent & Reference Laboratories 12.8.2. Hospital Laboratories 12.9. Europe Esoteric Testing Market Value Share Analysis, by Country 12.10. Europe Esoteric Testing Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Esoteric Testing Market Analysis, by Country 12.12. Germany Esoteric Testing Market Forecast, by Type 12.12.1. Infectious Diseases Testing 12.12.2. Endocrinology Testing 12.12.3. Oncology testing 12.12.4. Immunology Testing 12.12.5. Genetic Testing 12.12.6. Toxicology Testing 12.12.7. Neurology Testing 12.12.8. Others 12.13. Germany Esoteric Testing Market Forecast, by Technology 12.13.1. Chemiluminescence Immunoassay (CLIA) 12.13.2. Enzyme-linked Immunosorbent Assay (ELISA) 12.13.3. Mass Spectrometry 12.13.4. Real Time – PCR 12.13.5. Flow Cytometry 12.13.6. Radioimmunoassay 12.13.7. Others 12.14. Germany Esoteric Testing Market Forecast, by Laboratory Type 12.14.1. Independent & Reference Laboratories 12.14.2. Hospital Laboratories 12.15. U.K. Esoteric Testing Market Forecast, by Type 12.15.1. Infectious Diseases Testing 12.15.2. Endocrinology Testing 12.15.3. Oncology testing 12.15.4. Immunology Testing 12.15.5. Genetic Testing 12.15.6. Toxicology Testing 12.15.7. Neurology Testing 12.15.8. Others 12.16. U.K. Esoteric Testing Market Forecast, by Technology 12.16.1. Chemiluminescence Immunoassay (CLIA) 12.16.2. Enzyme-linked Immunosorbent Assay (ELISA) 12.16.3. Mass Spectrometry 12.16.4. Real Time – PCR 12.16.5. Flow Cytometry 12.16.6. Radioimmunoassay 12.16.7. Others 12.17. U.K. Esoteric Testing Market Forecast, by Laboratory Type 12.17.1. Independent & Reference Laboratories 12.17.2. Hospital Laboratories 12.18. France Esoteric Testing Market Forecast, by Type 12.18.1. Infectious Diseases Testing 12.18.2. Endocrinology Testing 12.18.3. Oncology testing 12.18.4. Immunology Testing 12.18.5. Genetic Testing 12.18.6. Toxicology Testing 12.18.7. Neurology Testing 12.18.8. Others 12.19. France Esoteric Testing Market Forecast, by Technology 12.19.1. Chemiluminescence Immunoassay (CLIA) 12.19.2. Enzyme-linked Immunosorbent Assay (ELISA) 12.19.3. Mass Spectrometry 12.19.4. Real Time – PCR 12.19.5. Flow Cytometry 12.19.6. Radioimmunoassay 12.19.7. Others 12.20. France Esoteric Testing Market Forecast, by Laboratory Type 12.20.1. Independent & Reference Laboratories 12.20.2. Hospital Laboratories 12.21. Italy Esoteric Testing Market Forecast, by Type 12.21.1. Infectious Diseases Testing 12.21.2. Endocrinology Testing 12.21.3. Oncology testing 12.21.4. Immunology Testing 12.21.5. Genetic Testing 12.21.6. Toxicology Testing 12.21.7. Neurology Testing 12.21.8. Others 12.22. Italy Esoteric Testing Market Forecast, by Technology 12.22.1. Chemiluminescence Immunoassay (CLIA) 12.22.2. Enzyme-linked Immunosorbent Assay (ELISA) 12.22.3. Mass Spectrometry 12.22.4. Real Time – PCR 12.22.5. Flow Cytometry 12.22.6. Radioimmunoassay 12.22.7. Others 12.23. Italy Esoteric Testing Market Forecast, by Laboratory Type 12.23.1. Independent & Reference Laboratories 12.23.2. Hospital Laboratories 12.24. Spain Esoteric Testing Market Forecast, by Type 12.24.1. Infectious Diseases Testing 12.24.2. Endocrinology Testing 12.24.3. Oncology testing 12.24.4. Immunology Testing 12.24.5. Genetic Testing 12.24.6. Toxicology Testing 12.24.7. Neurology Testing 12.24.8. Others 12.25. Spain Esoteric Testing Market Forecast, by Technology 12.25.1. Chemiluminescence Immunoassay (CLIA) 12.25.2. Enzyme-linked Immunosorbent Assay (ELISA) 12.25.3. Mass Spectrometry 12.25.4. Real Time – PCR 12.25.5. Flow Cytometry 12.25.6. Radioimmunoassay 12.25.7. Others 12.26. Spain Esoteric Testing Market Forecast, by Laboratory Type 12.26.1. Independent & Reference Laboratories 12.26.2. Hospital Laboratories 12.27. Rest of Europe Esoteric Testing Market Forecast, by Type 12.27.1. Infectious Diseases Testing 12.27.2. Endocrinology Testing 12.27.3. Oncology testing 12.27.4. Immunology Testing 12.27.5. Genetic Testing 12.27.6. Toxicology Testing 12.27.7. Neurology Testing 12.27.8. Others 12.28. Rest of Europe Esoteric Testing Market Forecast, by Technology 12.28.1. Chemiluminescence Immunoassay (CLIA) 12.28.2. Enzyme-linked Immunosorbent Assay (ELISA) 12.28.3. Mass Spectrometry 12.28.4. Real Time – PCR 12.28.5. Flow Cytometry 12.28.6. Radioimmunoassay 12.28.7. Others 12.29. Rest Of Europe Esoteric Testing Market Forecast, by Laboratory Type 12.29.1. Independent & Reference Laboratories 12.29.2. Hospital Laboratories 12.30. Europe Esoteric Testing Market Attractiveness Analysis 12.30.1. By Type 12.30.2. By Technology 12.30.3. By Laboratory Type 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Esoteric Testing Market Analysis 13.1. Key Findings 13.2. Asia Pacific Esoteric Testing Market Overview 13.3. Asia Pacific Esoteric Testing Market Value Share Analysis, by Type 13.4. Asia Pacific Esoteric Testing Market Forecast, by Type 13.4.1. Infectious Diseases Testing 13.4.2. Endocrinology Testing 13.4.3. Oncology testing 13.4.4. Immunology Testing 13.4.5. Genetic Testing 13.4.6. Toxicology Testing 13.4.7. Neurology Testing 13.4.8. Others 13.5. Asia Pacific Esoteric Testing Market Value Share Analysis, by Technology 13.6. Asia Pacific Esoteric Testing Market Forecast, by Technology 13.6.1. Chemiluminescence Immunoassay (CLIA) 13.6.2. Enzyme-linked Immunosorbent Assay (ELISA) 13.6.3. Mass Spectrometry 13.6.4. Real Time – PCR 13.6.5. Flow Cytometry 13.6.6. Radioimmunoassay 13.6.7. Others 13.7. Asia Pacific Esoteric Testing Market Value Share Analysis, by Laboratory Type 13.8. Asia Pacific Esoteric Testing Market Forecast, by Laboratory Type 13.8.1. Independent & Reference Laboratories 13.8.2. Hospital Laboratories 13.9. Asia Pacific Esoteric Testing Market Value Share Analysis, by Country 13.10. Asia Pacific Esoteric Testing Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Esoteric Testing Market Analysis, by Country 13.12. China Esoteric Testing Market Forecast, by Type 13.12.1. Infectious Diseases Testing 13.12.2. Endocrinology Testing 13.12.3. Oncology testing 13.12.4. Immunology Testing 13.12.5. Genetic Testing 13.12.6. Toxicology Testing 13.12.7. Neurology Testing 13.12.8. Others 13.13. China Esoteric Testing Market Forecast, by Technology 13.13.1. Chemiluminescence Immunoassay (CLIA) 13.13.2. Enzyme-linked Immunosorbent Assay (ELISA) 13.13.3. Mass Spectrometry 13.13.4. Real Time – PCR 13.13.5. Flow Cytometry 13.13.6. Radioimmunoassay 13.13.7. Others 13.14. China Esoteric Testing Market Forecast, by Laboratory Type 13.14.1. Independent & Reference Laboratories 13.14.2. Hospital Laboratories 13.15. India Esoteric Testing Market Forecast, by Type 13.15.1. Infectious Diseases Testing 13.15.2. Endocrinology Testing 13.15.3. Oncology testing 13.15.4. Immunology Testing 13.15.5. Genetic Testing 13.15.6. Toxicology Testing 13.15.7. Neurology Testing 13.15.8. Others 13.16. India Esoteric Testing Market Forecast, by Technology 13.16.1. Chemiluminescence Immunoassay (CLIA) 13.16.2. Enzyme-linked Immunosorbent Assay (ELISA) 13.16.3. Mass Spectrometry 13.16.4. Real Time – PCR 13.16.5. Flow Cytometry 13.16.6. Radioimmunoassay 13.16.7. Others 13.17. India Esoteric Testing Market Forecast, by Laboratory Type 13.17.1. Independent & Reference Laboratories 13.17.2. Hospital Laboratories 13.18. Japan Esoteric Testing Market Forecast, by Type 13.18.1. Infectious Diseases Testing 13.18.2. Endocrinology Testing 13.18.3. Oncology testing 13.18.4. Immunology Testing 13.18.5. Genetic Testing 13.18.6. Toxicology Testing 13.18.7. Neurology Testing 13.18.8. Others 13.19. Japan Esoteric Testing Market Forecast, by Technology 13.19.1. Chemiluminescence Immunoassay (CLIA) 13.19.2. Enzyme-linked Immunosorbent Assay (ELISA) 13.19.3. Mass Spectrometry 13.19.4. Real Time – PCR 13.19.5. Flow Cytometry 13.19.6. Radioimmunoassay 13.19.7. Others 13.20. Japan Esoteric Testing Market Forecast, by Laboratory Type 13.20.1. Independent & Reference Laboratories 13.20.2. Hospital Laboratories 13.21. ASEAN Esoteric Testing Market Forecast, by Type 13.21.1. Infectious Diseases Testing 13.21.2. Endocrinology Testing 13.21.3. Oncology testing 13.21.4. Immunology Testing 13.21.5. Genetic Testing 13.21.6. Toxicology Testing 13.21.7. Neurology Testing 13.21.8. Others 13.22. ASEAN Esoteric Testing Market Forecast, by Technology 13.22.1. Chemiluminescence Immunoassay (CLIA) 13.22.2. Enzyme-linked Immunosorbent Assay (ELISA) 13.22.3. Mass Spectrometry 13.22.4. Real Time – PCR 13.22.5. Flow Cytometry 13.22.6. Radioimmunoassay 13.22.7. Others 13.23. ASEAN Esoteric Testing Market Forecast, by Laboratory Type 13.23.1. Independent & Reference Laboratories 13.23.2. Hospital Laboratories 13.24. Rest of Asia Pacific Esoteric Testing Market Forecast, by Type 13.24.1. Infectious Diseases Testing 13.24.2. Endocrinology Testing 13.24.3. Oncology testing 13.24.4. Immunology Testing 13.24.5. Genetic Testing 13.24.6. Toxicology Testing 13.24.7. Neurology Testing 13.24.8. Others 13.25. Rest of Asia Pacific Esoteric Testing Market Forecast, by Technology 13.25.1. Chemiluminescence Immunoassay (CLIA) 13.25.2. Enzyme-linked Immunosorbent Assay (ELISA) 13.25.3. Mass Spectrometry 13.25.4. Real Time – PCR 13.25.5. Flow Cytometry 13.25.6. Radioimmunoassay 13.25.7. Others 13.26. Rest of Asia Pacific Esoteric Testing Market Forecast, by Laboratory Type 13.26.1. Independent & Reference Laboratories 13.26.2. Hospital Laboratories 13.27. Asia Pacific Esoteric Testing Market Attractiveness Analysis 13.27.1. By Type 13.27.2. By Technology 13.27.3. By Laboratory Type 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Esoteric Testing Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Esoteric Testing Market Overview 14.3. Middle East & Africa Esoteric Testing Market Value Share Analysis, by Type 14.4. Middle East & Africa Esoteric Testing Market Forecast, by Type 14.4.1. Infectious Diseases Testing 14.4.2. Endocrinology Testing 14.4.3. Oncology testing 14.4.4. Immunology Testing 14.4.5. Genetic Testing 14.4.6. Toxicology Testing 14.4.7. Neurology Testing 14.4.8. Others 14.5. Middle East & Africa Esoteric Testing Market Value Share Analysis, by Technology 14.6. Middle East & Africa Esoteric Testing Market Forecast, by Technology 14.6.1. Chemiluminescence Immunoassay (CLIA) 14.6.2. Enzyme-linked Immunosorbent Assay (ELISA) 14.6.3. Mass Spectrometry 14.6.4. Real Time – PCR 14.6.5. Flow Cytometry 14.6.6. Radioimmunoassay 14.6.7. Others 14.7. Middle East & Africa Esoteric Testing Market Value Share Analysis, by Laboratory Type 14.8. Middle East & Africa Esoteric Testing Market Forecast, by Laboratory Type 14.8.1. Independent & Reference Laboratories 14.8.2. Hospital Laboratories 14.9. Middle East & Africa Esoteric Testing Market Value Share Analysis, by Country 14.10. Middle East & Africa Esoteric Testing Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Esoteric Testing Market Analysis, by Country 14.12. GCC Esoteric Testing Market Forecast, by Type 14.12.1. Infectious Diseases Testing 14.12.2. Endocrinology Testing 14.12.3. Oncology testing 14.12.4. Immunology Testing 14.12.5. Genetic Testing 14.12.6. Toxicology Testing 14.12.7. Neurology Testing 14.12.8. Others 14.13. GCC Esoteric Testing Market Forecast, by Technology 14.13.1. Can 14.13.2. Pouch 14.13.3. P.E.T Jars 14.13.4. Bottles 14.14. GCC Esoteric Testing Market Forecast, by Laboratory Type 14.14.1. Independent & Reference Laboratories 14.14.2. Hospital Laboratories 14.15. South Africa Esoteric Testing Market Forecast, by Type 14.15.1. Infectious Diseases Testing 14.15.2. Endocrinology Testing 14.15.3. Oncology testing 14.15.4. Immunology Testing 14.15.5. Genetic Testing 14.15.6. Toxicology Testing 14.15.7. Neurology Testing 14.15.8. Others 14.16. South Africa Esoteric Testing Market Forecast, by Technology 14.16.1. Chemiluminescence Immunoassay (CLIA) 14.16.2. Enzyme-linked Immunosorbent Assay (ELISA) 14.16.3. Mass Spectrometry 14.16.4. Real Time – PCR 14.16.5. Flow Cytometry 14.16.6. Radioimmunoassay 14.16.7. Others 14.17. South Africa Esoteric Testing Market Forecast, by Laboratory Type 14.17.1. Independent & Reference Laboratories 14.17.2. Hospital Laboratories 14.18. Rest of Middle East & Africa Esoteric Testing Market Forecast, by Type 14.18.1. Infectious Diseases Testing 14.18.2. Endocrinology Testing 14.18.3. Oncology testing 14.18.4. Immunology Testing 14.18.5. Genetic Testing 14.18.6. Toxicology Testing 14.18.7. Neurology Testing 14.18.8. Others 14.19. Rest of Middle East & Africa Esoteric Testing Market Forecast, by Technology 14.19.1. Chemiluminescence Immunoassay (CLIA) 14.19.2. Enzyme-linked Immunosorbent Assay (ELISA) 14.19.3. Mass Spectrometry 14.19.4. Real Time – PCR 14.19.5. Flow Cytometry 14.19.6. Radioimmunoassay 14.19.7. Others 14.20. Rest of Middle East & Africa Esoteric Testing Market Forecast, by Laboratory Type 14.20.1. Independent & Reference Laboratories 14.20.2. Hospital Laboratories 14.21. Middle East & Africa Esoteric Testing Market Attractiveness Analysis 14.21.1. By Type 14.21.2. By Technology 14.21.3. By Laboratory Type 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Esoteric Testing Market Analysis 15.1. Key Findings 15.2. South America Esoteric Testing Market Overview 15.3. South America Esoteric Testing Market Value Share Analysis, by Type 15.4. South America Esoteric Testing Market Forecast, by Type 15.4.1. Infectious Diseases Testing 15.4.2. Endocrinology Testing 15.4.3. Oncology testing 15.4.4. Immunology Testing 15.4.5. Genetic Testing 15.4.6. Toxicology Testing 15.4.7. Neurology Testing 15.4.8. Others 15.5. South America Esoteric Testing Market Value Share Analysis, by Technology 15.6. South America Esoteric Testing Market Forecast, by Technology 15.6.1. Chemiluminescence Immunoassay (CLIA) 15.6.2. Enzyme-linked Immunosorbent Assay (ELISA) 15.6.3. Mass Spectrometry 15.6.4. Real Time – PCR 15.6.5. Flow Cytometry 15.6.6. Radioimmunoassay 15.6.7. Others 15.7. South America Esoteric Testing Market Value Share Analysis, by Laboratory Type 15.8. South America Esoteric Testing Market Forecast, by Laboratory Type 15.8.1. Independent & Reference Laboratories 15.8.2. Hospital Laboratories 15.9. South America Esoteric Testing Market Value Share Analysis, by Country 15.10. South America Esoteric Testing Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Esoteric Testing Market Analysis, by Country 15.12. Brazil Esoteric Testing Market Forecast, by Type 15.12.1. Infectious Diseases Testing 15.12.2. Endocrinology Testing 15.12.3. Oncology testing 15.12.4. Immunology Testing 15.12.5. Genetic Testing 15.12.6. Toxicology Testing 15.12.7. Neurology Testing 15.12.8. Others 15.13. Brazil Esoteric Testing Market Forecast, by Technology 15.13.1. Chemiluminescence Immunoassay (CLIA) 15.13.2. Enzyme-linked Immunosorbent Assay (ELISA) 15.13.3. Mass Spectrometry 15.13.4. Real Time – PCR 15.13.5. Flow Cytometry 15.13.6. Radioimmunoassay 15.13.7. Others 15.14. Brazil Esoteric Testing Market Forecast, by Laboratory Type 15.14.1. Independent & Reference Laboratories 15.14.2. Hospital Laboratories 15.15. Mexico Esoteric Testing Market Forecast, by Type 15.15.1. Infectious Diseases Testing 15.15.2. Endocrinology Testing 15.15.3. Oncology testing 15.15.4. Immunology Testing 15.15.5. Genetic Testing 15.15.6. Toxicology Testing 15.15.7. Neurology Testing 15.15.8. Others 15.16. Mexico Esoteric Testing Market Forecast, by Technology 15.16.1. Chemiluminescence Immunoassay (CLIA) 15.16.2. Enzyme-linked Immunosorbent Assay (ELISA) 15.16.3. Mass Spectrometry 15.16.4. Real Time – PCR 15.16.5. Flow Cytometry 15.16.6. Radioimmunoassay 15.16.7. Others 15.17. Mexico Esoteric Testing Market Forecast, by Laboratory Type 15.17.1. Independent & Reference Laboratories 15.17.2. Hospital Laboratories 15.18. Rest of South America Esoteric Testing Market Forecast, by Type 15.18.1. Infectious Diseases Testing 15.18.2. Endocrinology Testing 15.18.3. Oncology testing 15.18.4. Immunology Testing 15.18.5. Genetic Testing 15.18.6. Toxicology Testing 15.18.7. Neurology Testing 15.18.8. Others 15.19. Rest of South America Esoteric Testing Market Forecast, by Technology 15.19.1. Chemiluminescence Immunoassay (CLIA) 15.19.2. Enzyme-linked Immunosorbent Assay (ELISA) 15.19.3. Mass Spectrometry 15.19.4. Real Time – PCR 15.19.5. Flow Cytometry 15.19.6. Radioimmunoassay 15.19.7. Others 15.20. Rest of South America Esoteric Testing Market Forecast, by Laboratory Type 15.20.1. Independent & Reference Laboratories 15.20.2. Hospital Laboratories 15.21. South America Esoteric Testing Market Attractiveness Analysis 15.21.1. By Type 15.21.2. By Technology 15.21.3. By Laboratory Type 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Laboratory Corporation of America Holdings 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Manufacturing Footprint 16.3.2. Quest Diagnostics 16.3.3. Opko Health 16.3.4. Miraca Holdings 16.3.5. Myriad Genetics 16.3.6. Sonic Healthcare 16.3.7. Primary Health Care 16.3.8. Healthscope 16.3.9. Foundation Medicine 16.3.10. ACM Global Laboratories 16.3.11. Arup Laboratories 16.3.12. Fulgent Genetics 16.3.13. Invitae 16.3.14. Mayo Medical Laboratories 16.3.15. Spectra Laboratories 16.3.16. Genomic Health, Inc. 16.3.17. American Medical Laboratories 16.3.18. Gold Standard Diagnostics Corp 16.3.19. ZeptoMetrix Corporation. 16.3.20. Genomic Health 16.3.21. Foundation Medicine 16.3.22. Mayo Medical Laboratories 16.3.23. Eurofins Scientific 16.3.24. Unilabs 16.3.25. SYNLAB International 16.3.26. Enzo Biochem 16.3.27. Clinical Reference Laboratory 16.3.28. Sequenom 16.3.29. American Pathology Partners 17. Primary Key Insights

Inquiry Before Buying

Request Sample

About This Report

Report ID1297
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now